Motilal Oswal Sees 25% EBITDA CAGR at Aster DM Through FY28, Sets Rs 910 Target
Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that merger synergies, capacity additions and improving operating metrics can drive a strong earnings cycle. The brokerage expects the hospital operator’s revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28.
